Stockholder Sues SciClone Pharmaceuticals, Others Over Proposed Merger
September 7, 2017 SciClone Pharmaceuticals, Inc., its board of directors, Silver Biotech Investment Limited, and Silver Delaware Investment Limited are the defendants in a proposed class action lawsuit alleging they misled investors regarding a proposed merger.